Global Small Molecule Active Pharmaceutical Ingredient Market Insights, Forecast to 2025

SKU ID :QYR-14130390 | Published Date: 23-Apr-2019 | No. of pages: 128
Table of Contents 1 Study Coverage 1.1 Small Molecule Active Pharmaceutical Ingredient Product 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Small Molecule Active Pharmaceutical Ingredient Market Size Growth Rate by Product 1.4.2 Standard API 1.4.3 High Potency API 1.5 Market by End User 1.5.1 Global Small Molecule Active Pharmaceutical Ingredient Market Size Growth Rate by End User 1.5.2 Cardiovascular Diseases 1.5.3 Respiratory Disorders 1.5.4 Infectious Diseases 1.5.5 Others 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Small Molecule Active Pharmaceutical Ingredient Market Size 2.1.1 Global Small Molecule Active Pharmaceutical Ingredient Revenue 2014-2025 2.1.2 Global Small Molecule Active Pharmaceutical Ingredient Sales 2014-2025 2.2 Small Molecule Active Pharmaceutical Ingredient Growth Rate by Regions 2.2.1 Global Small Molecule Active Pharmaceutical Ingredient Sales by Regions 2.2.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 Small Molecule Active Pharmaceutical Ingredient Sales by Manufacturers 3.1.1 Small Molecule Active Pharmaceutical Ingredient Sales by Manufacturers 3.1.2 Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Manufacturers 3.1.3 Global Small Molecule Active Pharmaceutical Ingredient Market Concentration Ratio (CR5 and HHI) 3.2 Small Molecule Active Pharmaceutical Ingredient Revenue by Manufacturers 3.2.1 Small Molecule Active Pharmaceutical Ingredient Revenue by Manufacturers (2014-2019) 3.2.2 Small Molecule Active Pharmaceutical Ingredient Revenue Share by Manufacturers (2014-2019) 3.3 Small Molecule Active Pharmaceutical Ingredient Price by Manufacturers 3.4 Small Molecule Active Pharmaceutical Ingredient Manufacturing Base Distribution, Product Types 3.4.1 Small Molecule Active Pharmaceutical Ingredient Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Small Molecule Active Pharmaceutical Ingredient Product Type 3.4.3 Date of International Manufacturers Enter into Small Molecule Active Pharmaceutical Ingredient Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Product 4.1 Global Small Molecule Active Pharmaceutical Ingredient Sales by Product 4.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue by Product 4.3 Small Molecule Active Pharmaceutical Ingredient Price by Product 5 Breakdown Data by End User 5.1 Overview 5.2 Global Small Molecule Active Pharmaceutical Ingredient Breakdown Data by End User 6 North America 6.1 North America Small Molecule Active Pharmaceutical Ingredient by Countries 6.1.1 North America Small Molecule Active Pharmaceutical Ingredient Sales by Countries 6.1.2 North America Small Molecule Active Pharmaceutical Ingredient Revenue by Countries 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America Small Molecule Active Pharmaceutical Ingredient by Product 6.3 North America Small Molecule Active Pharmaceutical Ingredient by End User 7 Europe 7.1 Europe Small Molecule Active Pharmaceutical Ingredient by Countries 7.1.1 Europe Small Molecule Active Pharmaceutical Ingredient Sales by Countries 7.1.2 Europe Small Molecule Active Pharmaceutical Ingredient Revenue by Countries 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe Small Molecule Active Pharmaceutical Ingredient by Product 7.3 Europe Small Molecule Active Pharmaceutical Ingredient by End User 8 Asia Pacific 8.1 Asia Pacific Small Molecule Active Pharmaceutical Ingredient by Countries 8.1.1 Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales by Countries 8.1.2 Asia Pacific Small Molecule Active Pharmaceutical Ingredient Revenue by Countries 8.1.3 China 8.1.4 Japan 8.1.5 Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Malaysia 8.1.10 Philippines 8.1.11 Thailand 8.1.12 Vietnam 8.1.13 Singapore 8.2 Asia Pacific Small Molecule Active Pharmaceutical Ingredient by Product 8.3 Asia Pacific Small Molecule Active Pharmaceutical Ingredient by End User 9 Central & South America 9.1 Central & South America Small Molecule Active Pharmaceutical Ingredient by Countries 9.1.1 Central & South America Small Molecule Active Pharmaceutical Ingredient Sales by Countries 9.1.2 Central & South America Small Molecule Active Pharmaceutical Ingredient Revenue by Countries 9.1.3 Brazil 9.2 Central & South America Small Molecule Active Pharmaceutical Ingredient by Product 9.3 Central & South America Small Molecule Active Pharmaceutical Ingredient by End User 10 Middle East and Africa 10.1 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient by Countries 10.1.1 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales by Countries 10.1.2 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Revenue by Countries 10.1.3 GCC Countries 10.1.4 Turkey 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient by Product 10.3 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient by End User 11 Company Profiles 11.1 Johnson Matthey 11.1.1 Johnson Matthey Company Details 11.1.2 Company Business Overview 11.1.3 Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2014-2019) 11.1.4 Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Products Offered 11.1.5 Johnson Matthey Recent Development 11.2 Siegfried Holding AG 11.2.1 Siegfried Holding AG Company Details 11.2.2 Company Business Overview 11.2.3 Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2014-2019) 11.2.4 Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Products Offered 11.2.5 Siegfried Holding AG Recent Development 11.3 Pfizer 11.3.1 Pfizer Company Details 11.3.2 Company Business Overview 11.3.3 Pfizer Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2014-2019) 11.3.4 Pfizer Small Molecule Active Pharmaceutical Ingredient Products Offered 11.3.5 Pfizer Recent Development 11.4 Sanofi S.A. 11.4.1 Sanofi S.A. Company Details 11.4.2 Company Business Overview 11.4.3 Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2014-2019) 11.4.4 Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Products Offered 11.4.5 Sanofi S.A. Recent Development 11.5 Novartis AG, 11.5.1 Novartis AG, Company Details 11.5.2 Company Business Overview 11.5.3 Novartis AG, Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2014-2019) 11.5.4 Novartis AG, Small Molecule Active Pharmaceutical Ingredient Products Offered 11.5.5 Novartis AG, Recent Development 11.6 Bristol-Myers Squibb 11.6.1 Bristol-Myers Squibb Company Details 11.6.2 Company Business Overview 11.6.3 Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2014-2019) 11.6.4 Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Products Offered 11.6.5 Bristol-Myers Squibb Recent Development 11.7 Boehringer Ingelheim GmbH 11.7.1 Boehringer Ingelheim GmbH Company Details 11.7.2 Company Business Overview 11.7.3 Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2014-2019) 11.7.4 Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Products Offered 11.7.5 Boehringer Ingelheim GmbH Recent Development 11.8 GlaxoSmithKline 11.8.1 GlaxoSmithKline Company Details 11.8.2 Company Business Overview 11.8.3 GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2014-2019) 11.8.4 GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Products Offered 11.8.5 GlaxoSmithKline Recent Development 11.9 Albany Molecular Research Inc. 11.9.1 Albany Molecular Research Inc. Company Details 11.9.2 Company Business Overview 11.9.3 Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2014-2019) 11.9.4 Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Products Offered 11.9.5 Albany Molecular Research Inc. Recent Development 11.10 Bachem Holding AG 11.10.1 Bachem Holding AG Company Details 11.10.2 Company Business Overview 11.10.3 Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2014-2019) 11.10.4 Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Products Offered 11.10.5 Bachem Holding AG Recent Development 11.11 PCAS 11.12 Patheon N.V. 11.13 AstraZeneca 11.14 Johnson & Johnson 11.15 Merck & Co, Inc. 11.16 BASF SE 11.17 Catalent Inc. 11.18 Teva Pharmaceuticals 11.19 Roche 11.20 Cambrex Corporation 11.21 GILEAD Science Inc. 12 Future Forecast 12.1 Small Molecule Active Pharmaceutical Ingredient Market Forecast by Regions 12.1.1 Global Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Regions 2019-2025 12.1.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Regions 2019-2025 12.2 Small Molecule Active Pharmaceutical Ingredient Market Forecast by Product 12.2.1 Global Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Product 2019-2025 12.2.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Product 2019-2025 12.3 Small Molecule Active Pharmaceutical Ingredient Market Forecast by End User 12.4 North America Small Molecule Active Pharmaceutical Ingredient Forecast 12.5 Europe Small Molecule Active Pharmaceutical Ingredient Forecast 12.6 Asia Pacific Small Molecule Active Pharmaceutical Ingredient Forecast 12.7 Central & South America Small Molecule Active Pharmaceutical Ingredient Forecast 12.8 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Forecast 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Macroscopic Indicators 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Small Molecule Active Pharmaceutical Ingredient Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer
List of Tables and Figures Figure Small Molecule Active Pharmaceutical Ingredient Product Picture Table Small Molecule Active Pharmaceutical Ingredient Market Segments Table Key Manufacturers Small Molecule Active Pharmaceutical Ingredient Covered Table Global Small Molecule Active Pharmaceutical Ingredient Market Size Growth Rate by Product 2019-2025 (MT) & (Million US$) Figure Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Product 2014-2025 Figure Standard API Product Picture Table Major Manufacturers of Standard API Figure High Potency API Product Picture Table Major Manufacturers of High Potency API Table Global Small Molecule Active Pharmaceutical Ingredient Market Size Growth Rate by End User 2019-2025 (MT) Figure Cardiovascular Diseases Figure Respiratory Disorders Figure Infectious Diseases Figure Others Figure Small Molecule Active Pharmaceutical Ingredient Report Years Considered Figure Global Small Molecule Active Pharmaceutical Ingredient Market Size 2014-2025 (Million US$) Figure Global Small Molecule Active Pharmaceutical Ingredient Sales 2014-2025 (MT) Table Global Small Molecule Active Pharmaceutical Ingredient Market Size by Regions 2014-2019 (MT) & (Million US$) Table Global Small Molecule Active Pharmaceutical Ingredient Sales by Regions 2014-2019 (MT) Table Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Regions 2014-2019 Figure Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Regions 2014-2019 Figure 2018 Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Regions Table Global Small Molecule Active Pharmaceutical Ingredient Revenue by Regions 2014-2019 (Million US$) Table Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Regions 2014-2019 Figure Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Regions 2014-2019 Figure 2018 Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Regions Table Global Small Molecule Active Pharmaceutical Ingredient Sales by Manufacturers (2014-2019) (MT) Table Global Small Molecule Active Pharmaceutical Ingredient Sales Share by Manufacturers (2014-2019) Figure Global Small Molecule Active Pharmaceutical Ingredient Sales Share by Manufacturers in 2018 Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Small Molecule Active Pharmaceutical Ingredient Revenue by Manufacturers (2014-2019) (Million USD) Table Small Molecule Active Pharmaceutical Ingredient Revenue Share by Manufacturers (2014-2019) Figure Small Molecule Active Pharmaceutical Ingredient Value Share by Manufacturers in 2018 Table Key Manufacturers Small Molecule Active Pharmaceutical Ingredient Price (2014-2019) (USD/Kg) Table Small Molecule Active Pharmaceutical Ingredient Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers Small Molecule Active Pharmaceutical Ingredient Product Type Table Date of International Manufacturers Enter into Small Molecule Active Pharmaceutical Ingredient Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global Small Molecule Active Pharmaceutical Ingredient Sales by Product (2014-2019) (MT) Table Global Small Molecule Active Pharmaceutical Ingredient Sales Share by Product (2014-2019) Figure Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Product (2014-2019) Figure Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Product in 2018 Table Global Small Molecule Active Pharmaceutical Ingredient Revenue by Product (2014-2019) (Million US$) Table Global Small Molecule Active Pharmaceutical Ingredient Revenue Share by Product (2014-2019) Figure Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Product (2014-2019) Figure Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Product in 2018 Table Small Molecule Active Pharmaceutical Ingredient Price by Product 2014-2019 (USD/Kg) Table Global Small Molecule Active Pharmaceutical Ingredient Sales by End User (2014-2019) (MT) Table Global Small Molecule Active Pharmaceutical Ingredient Sales Share by End User (2014-2019) Figure Global Sales Small Molecule Active Pharmaceutical Ingredient Market Share by End User (2014-2019) Figure Global Sales Small Molecule Active Pharmaceutical Ingredient Market Share by End User in 2018 Figure North America Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate 2014-2019 (MT) Figure North America Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate 2014-2019 (Million US$) Table North America Small Molecule Active Pharmaceutical Ingredient Sales by Countries (2014-2019) (MT) Table North America Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Countries (2014-2019) Figure 2018 North America Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Countries Table North America Small Molecule Active Pharmaceutical Ingredient Revenue by Countries (2014-2019) (Million US$) Table North America Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Countries (2014-2019) Figure 2018 North America Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Countries Figure United States Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2014-2019) (MT) Figure United States Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2014-2019) (MT) Figure Canada Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2014-2019) (MT) Figure Canada Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2014-2019) (Million US$) Figure Mexico Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2014-2019) (MT) Figure Mexico Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2014-2019) (Million US$) Table North America Small Molecule Active Pharmaceutical Ingredient Sales by Product (2014-2019) (MT) Table North America Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Product (2014-2019) Figure 2018 North America Small Molecule Active Pharmaceutical Ingredient Market Share by Product Table North America Small Molecule Active Pharmaceutical Ingredient Sales by End User (2014-2019) (MT) Table North America Small Molecule Active Pharmaceutical Ingredient Sales Market Share by End User (2014-2019) Figure 2018 North America Small Molecule Active Pharmaceutical Ingredient Market Share by End User Figure Europe Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate 2014-2019 (MT) Figure Europe Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate 2014-2019 (Million US$) Table Europe Small Molecule Active Pharmaceutical Ingredient Sales by Countries (2014-2019) (MT) Table Europe Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Countries (2014-2019) Figure 2018 Europe Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Countries Table Europe Small Molecule Active Pharmaceutical Ingredient Revenue by Countries (2014-2019) (Million US$) Table Europe Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Countries (2014-2019) Figure 2018 Europe Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Countries Figure Germany Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2014-2019) (MT) Figure Germany Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2014-2019) (Million US$) Figure France Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2014-2019) (MT) Figure France Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2014-2019) (Million US$) Figure UK Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2014-2019) (MT) Figure UK Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2014-2019) (Million US$) Figure Italy Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2014-2019) (MT) Figure Italy Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2014-2019) (Million US$) Figure Russia Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2014-2019) (MT) Figure Russia Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2014-2019) (Million US$) Table Europe Small Molecule Active Pharmaceutical Ingredient Sales by Product (2014-2019) (MT) Table Europe Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Product (2014-2019) Figure 2018 Europe Small Molecule Active Pharmaceutical Ingredient Market Share by Product Table Europe Small Molecule Active Pharmaceutical Ingredient Sales by End User (2014-2019) (MT) Table Europe Small Molecule Active Pharmaceutical Ingredient Sales Market Share by End User (2014-2019) Figure 2018 Europe Small Molecule Active Pharmaceutical Ingredient Market Share by End User Figure Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate 2014-2019 (MT) Figure Asia Pacific Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate 2014-2019 (Million US$) Table Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales by Countries (2014-2019) (MT) Table Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Countries Table Asia Pacific Small Molecule Active Pharmaceutical Ingredient Revenue by Countries (2014-2019) (Million US$) Table Asia Pacific Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Countries Figure China Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2014-2019) (MT) Figure China Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2014-2019) (Million US$) Figure Japan Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2014-2019) (MT) Figure Japan Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2014-2019) (Million US$) Figure Korea Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2014-2019) (MT) Figure Korea Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2014-2019) (Million US$) Figure India Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2014-2019) (MT) Figure India Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2014-2019) (Million US$) Figure Australia Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2014-2019) (MT) Figure Australia Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2014-2019) (Million US$) Figure Indonesia Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2014-2019) (MT) Figure Indonesia Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2014-2019) (Million US$) Figure Malaysia Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2014-2019) (MT) Figure Malaysia Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2014-2019) (Million US$) Figure Philippines Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2014-2019) (MT) Figure Philippines Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2014-2019) (Million US$) Figure Thailand Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2014-2019) (MT) Figure Thailand Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2014-2019) (Million US$) Figure Vietnam Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2014-2019) (MT) Figure Vietnam Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2014-2019) (Million US$) Figure Singapore Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2014-2019) (MT) Figure Singapore Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2014-2019) (Million US$) Table Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales by Product (2014-2019) (MT) Table Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Product (2014-2019) Figure 2018 Asia Pacific Small Molecule Active Pharmaceutical Ingredient Market Share by Product Table Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales by End User (2014-2019) (MT) Table Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales Market Share by End User (2014-2019) Figure 2018 Asia Pacific Small Molecule Active Pharmaceutical Ingredient Market Share by End User Figure Central & South America Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate 2014-2019 (MT) Figure Central & South America Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate 2014-2019 (Million US$) Table Central & South America Small Molecule Active Pharmaceutical Ingredient Sales by Countries (2014-2019) (MT) Table Central & South America Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Countries (2014-2019) Figure 2018 Central & South America Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Countries Table Central & South America Small Molecule Active Pharmaceutical Ingredient Revenue by Countries (2014-2019) (Million US$) Table Central & South America Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Countries (2014-2019) Figure 2018 Central & South America Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Countries Figure Brazil Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2014-2019) (MT) Figure Brazil Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2014-2019) (Million US$) Figure Argentina Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2014-2019) (MT) Figure Argentina Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2014-2019) (Million US$) Table Central & South America Small Molecule Active Pharmaceutical Ingredient Sales by Product (2014-2019) (MT) Table Central & South America Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Product (2014-2019) Figure 2018 Central & South America Small Molecule Active Pharmaceutical Ingredient Market Share by Product Table Central & South America Small Molecule Active Pharmaceutical Ingredient Sales by End User (2014-2019) (MT) Table Central & South America Small Molecule Active Pharmaceutical Ingredient Sales Market Share by End User (2014-2019) Figure 2018 Central & South America Small Molecule Active Pharmaceutical Ingredient Market Share by End User Figure Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate 2014-2019 (MT) Figure Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate 2014-2019 (Million US$) Table Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales by Countries (2014-2019) (MT) Table Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Countries Table Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Revenue by Countries (2014-2019) (Million US$) Table Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Countries Figure GCC Countries Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2014-2019) (MT) Figure GCC Countries Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2014-2019) (Million US$) Figure Turkey Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2014-2019) (MT) Figure Turkey Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2014-2019) (Million US$) Figure Egypt Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2014-2019) (MT) Figure Egypt Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2014-2019) (Million US$) Figure South Africa Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2014-2019) (MT) Figure South Africa Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2014-2019) (Million US$) Table Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales by Product (2014-2019) (MT) Table Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Product (2014-2019) Figure 2018 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Market Share by Product Table Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales by End User (2014-2019) (MT) Table Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales Market Share by End User (2014-2019) Figure 2018 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Market Share by End User Table Johnson Matthey Company Details Table Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019) Table Johnson Matthey Recent Development Table Siegfried Holding AG Company Details Table Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019) Table Siegfried Holding AG Recent Development Table Pfizer Company Details Table Pfizer Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019) Table Pfizer Recent Development Table Sanofi S.A. Company Details Table Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019) Table Sanofi S.A. Recent Development Table Novartis AG, Company Details Table Novartis AG, Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019) Table Novartis AG, Recent Development Table Bristol-Myers Squibb Company Details Table Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019) Table Bristol-Myers Squibb Recent Development Table Boehringer Ingelheim GmbH Company Details Table Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019) Table Boehringer Ingelheim GmbH Recent Development Table GlaxoSmithKline Company Details Table GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019) Table GlaxoSmithKline Recent Development Table Albany Molecular Research Inc. Company Details Table Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019) Table Albany Molecular Research Inc. Recent Development Table Bachem Holding AG Company Details Table Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019) Table Bachem Holding AG Recent Development Table PCAS Company Details Table Patheon N.V. Company Details Table AstraZeneca Company Details Table Johnson & Johnson Company Details Table Merck & Co, Inc. Company Details Table BASF SE Company Details Table Catalent Inc. Company Details Table Teva Pharmaceuticals Company Details Table Roche Company Details Table Cambrex Corporation Company Details Table GILEAD Science Inc. Company Details Table Global Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Regions 2019-2025 (MT) Table Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share Forecast by Regions 2019-2025 Table Global Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Regions 2019-2025 (Million US$) Table Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share Forecast by Regions 2019-2025 Table Global Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Product 2019-2025 (MT) Table Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share Forecast by Product 2019-2025 Table Global Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Product 2019-2025 (Million US$) Table Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share Forecast by Product 2019-2025 Table Global Small Molecule Active Pharmaceutical Ingredient Sales Forecast by End User 2019-2025 (MT) Table Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share Forecast by End User 2019-2025 Figure North America Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate Forecast (2019-2025) (MT) Figure North America Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Europe Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate Forecast (2019-2025) (MT) Figure Europe Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate Forecast (2019-2025) (MT) Figure Asia Pacific Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Central & South America Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate Forecast (2019-2025) (MT) Figure Central & South America Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate Forecast (2019-2025) (MT) Figure Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate Forecast (2019-2025) (Million US$) Table Small Molecule Active Pharmaceutical Ingredient Value Chain Table Small Molecule Active Pharmaceutical Ingredient Customers List Table Small Molecule Active Pharmaceutical Ingredient Distributors List Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources
Johnson Matthey Siegfried Holding AG Pfizer Sanofi S.A. Novartis AG, Bristol-Myers Squibb Boehringer Ingelheim GmbH GlaxoSmithKline Albany Molecular Research Inc. Bachem Holding AG PCAS Patheon N.V. AstraZeneca Johnson & Johnson Merck & Co, Inc. BASF SE Catalent Inc. Teva Pharmaceuticals Roche Cambrex Corporation GILEAD Science Inc.
  • PRICE
  • $3900
    $7800
    $5850
    Buy Now

Our Clients